It has been previously stated in multiple videos and news sources that I have been watching, and what I do is take notes and do my own research on the subjects as follow-ups or debunking what I know that the world is being told.
Here's an example of what you can buy online for the holiday season!
These are the links from the above items if you are still doubting a POPE!
https://www.origene.com/blog/the-revival-of-lentiviral-vectors
https://www.origene.com/blog/handling-lentivirus
https://www.origene.com/blog/ace2-receptor-for-covid-19-invasion
Moving forward, I am going to request that you check your doubt in at the lobby prior to becoming a member, as I am quite sure that you are, have been, and some are planning on investing your POPE, fate, prayers, money into someone who has never done an actual single thing for your on earth, yet you still believe and follow him. (You have had things happen to you that you attribute to him, there is a factual proven difference. Assante)
The recent outbreak of COVID-19 that started in Wuhan, China, has spread globally and caused major loss in human lives. The latest research has reported that ACE2 (angiotensin converting enzyme 2) is a functional receptor for COVID-19 to latch on and enter.View All COVID19 Products
The coronavirus enters human cell through the interaction of virus Spike protein (S protein) and ACE2 receptor on the cell membrane.
What is ACE2?
ACE2 is a carboxypeptidase that shares significant homologue with ACE. Human ACE2 is a type I integral membrane protein made of 805 amino acids (AA). It contains a 17 AA N-terminal signal area, a 22 AA hydrophobic transmembrane near the C-terminus and a 43 AA cytoplasmic domain. It is expressed in spleen, liver, retina, placenta, brain tissue, heart, coronary arteries, arteries, veins, endothelial tissue, macrophages, gastrointestinal system, lung alveolar epithelial cells and other tissue cells. The expression pattern suggests that it may play a role in the regulation of cardiovascular, renal and fertility.
It is found that ACE2 plays an important role in the infection of SARS-Cov and COVID-19. To many researchers, ACE2 has become a hot target due to the recent outbreak of COVID-19.
How does coronavirus infect through ACE2?
The first step of an infection is when coronavirus binds to a functional receptor on the surface of a human cell. For both SARS-Cov and COVID-19, that receptor is ACE2. ACE2 is expressed in alveolar epithelial cells and enterocytes of the small intestine. Both of which are the primary target cells for coronavirus infection.
The surface S protein of the coronavirus binds to ACE2 receptor on the host cell. The affinity of RBD (Receptor Binding Domain) of the S-protein and ACE2 determine the susceptibility of the host. S-protein binds to the claw-like structure of ACE2. The binding creates fusion between the viral and host cell membrane.
The RBD of the S-protein can be engineered to modify its binding affinity with ACE2.
Small molecules or antibodies that can block the binding of S-Protein and ACE2 could be designed as therapeutic agents for the coronavirus infection.
DO YOU READ THE LAST FUNKIN LINES OF THE ABOVE PICTURE?!
Figure 1 and Figure 2 credit to paper Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS, by Yushun Wan, Jian Shang, Rachel Graham, Ralph S Baric, Fang Li. Journal of Virology, 2020; DOI: 10.1128/JVI.00127-20.
They talk backwards in here, when they say "treatment," they mean their issues with getting you infected. That was the jargon never changes to the eyes.
POPEtential Treatments
Based on the interaction between the S-protein and ACE2 on the cell surface, several potential therapeutic agents have been proposed by researchers to treat coronavirus infection.
Use small receptor-binding domain (RBD) from the coronavirus S protein as a blocking agent that binds to the ACE2 receptor.
Develop an antibody or a single chain antibody fragment (scFv) to bind to ACE2 receptor to prevent coronavirus attachment.
Use the ACE2 extracellular domain as a bait to bind to the spike protein that directly target coronavirus. This strategy converts soluble ACE2 into an immunoadhesin format fused to an immunoglobulin Fc domain (ACE2-Fc).
Figure 3. Potential Therapeutic Agents to Block Coronavirus Infection
Figure 3 credit to Therapeutic Strategies in an Outbreak Scenario to Treat the Novel Coronavirus Originating in Wuhan, China. [Version 2; peer review: 1 approved], by Kruse RL (2020). https://doi.org/10.12688/f1000research.22211.2
Any of the above potential treatments need to be fully tested in animal models and in clinical trials. The potential side effects also need to be investigated.
Biological functions of ACE2
ACE2 is not designed as the receptor of infectious viruses. It also serves many other functions:
ACE2 in Vasodilation
ACE2 is a transporter partner for amino acid
How can we help?
As your gene company, (Insert Gene Company Name Here) provides a comprehensive set of tools for ACE2 study including:
ACE2 Purified Protein
ACE2 cDNA Clones
ACE2 Antibodies
ACE2 RNAi
ACE2 CRISPR Knock-out Kits
ACE2 CRISPR Activation Kits
References
Renhong Yan, Yuanyuan Zhang, Yaning Li, Lu Xia, and Qiang Zhou(2020). Structure of dimeric full-length human ACE2 in complex with B0AT1. doi.org/10.1101/2020.02.17.951848.
Yushun Wan, Jian Shang, Rachel Graham, Ralph S Baric, Fang Li(2020). Receptor recognition by novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS. Journal of Virology, 2020; DOI: 10.1128/JVI.00127-20.
Zhu X, Liu Q, Du L, Lu L, Jiang S(2013). Receptor-binding domain as a target for developing SARS vaccines. J Thorac Dis.5 suppl 2:S142-8
Jiang S. et al (2019). The spike protein of SARS-CoV—a target for vaccine and therapeutic development. Nat Rev Microbiol. 7:226-36.
Wu, F. et al (2020). A new coronavirus associated with human respiratory disease in China. Nature https://doi. org/10.1038/s41586-020-2008-3.
Kuba K et al., (2010). Trilogy of ACE2: A peptidase in the renin–angiotensin system, a SARS receptor, and a partner for amino acid transporters. PharmacolTher. 128(1):119-28.
M. Donoghue, F. Hsieh, E. Baronas, K. Godbout, M. Gosselin, N. Stagliano, M. Donovan, B. Woolf, K. Robison, R. Jeyaseelan, et al (2000). A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9,Circ Res, 87 (2000), pp. E1-E9
W. Li, M.J. Moore, N. Vasilieva, J. Sui, S.K. Wong, M.A. Berne, M. Somasundaran, J.L. Sullivan, K. Luzuriaga, T.C. Greenough, et al (2003).Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus,Nature, 426 (2003), pp. 450-454
Coming soon for our Village family members both current and future;
2018 Nobel Prize in Medicine Awarded to 2 Immunotherapy Researchers
Oct 23, 2018
The 2018 Noble Prize in Physiology or Medicine was awarded on Monday, October 1st, 2018 to Tasuku Honjo of Japan and James P. Allison of the United States for discovering Immuno Oncology Checkpoint Proteins (I-O) that have fundamentally changed the way some cancers are treated. Unlike previous cancer therapies that target cancer cells directly, their discovery targets the “brakes” of the host immune system. Role...
To be, or not to be, that is the question.
Oct 02, 2018
As your gene company, OriGene wants to offer you, the molecular biologists, a complete solution: not just expression-ready clones, but also transfection-ready purified plasmid DNA. For a limited time, we are offering 20,000 mouse expression clones for $48 per vial of 10ug plasmid DNA. With this, you will skip the tedious work of transformation / E. coli culture / plasmid prep / sequence verification /...
MAGEA4 is Hot Right Now!
Jul 16, 2018
What makes MAGEA4 a hot target? Melanoma Antigen Gene (MAGE) type A4 acts as an activator of Trans-lesion synthesis, an error-prone mechanism for DNA repair. Interest in the antigen began when the MAGE proteins were found to only express in the testes, placenta, and several types of tumors. This differentiation made MAGEA4 a perfect immunotherapeutic target, and the excitement in the research community ignited. A...
Biosafety considerations when handling lentivirus
Jun 14, 2018
Human ingenuity has turned the sinister HIV-1 virus into a convenient laboratory tool for gene delivery as lentiviral vector. After multiple rounds of engineering, the 3rd generation of lenti viral system has diminished the possibility for the lab-made virus to replicate and to impose health risk to laboratory staff. While it is important that we treat all laboratory tools with respect, there is no reason...
Antibody Validation – How do we confirm the specificity of an antibody?
May 12, 2018
One common question that scientists always ask when they get the signal from an antibody based assay is: "Does this signal truly represent the presence and quantity of my protein?" Antibody specificity is always a concern for scientists. Even though there are a number of validation methods that have been used for the specificity testing, the data is often over-interpreted. Research data from various groups...
Let's learn from each other and take it to the next generation gift-wrapped because we love em!
Share if you care, Share if you don't!
Somebody cares enough for the both of us!
Sign up before time's up!
